Secor Capital Advisors’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-23,014
| Closed | -$65K | – | 566 |
|
|
2018
Q2 | $65K | Sell |
23,014
-37,364
| -62% | -$106K | 0.01% | 402 |
|
|
2018
Q1 | $224K | Sell |
60,378
-374
| -0.6% | -$1.39K | 0.02% | 407 |
|
|
2017
Q4 | $175K | Sell |
60,752
-89,065
| -59% | -$257K | 0.01% | 383 |
|
|
2017
Q3 | $673K | Buy |
149,817
+95,725
| +177% | +$430K | 0.06% | 266 |
|
|
2017
Q2 | $248K | Buy |
+54,092
| New | +$248K | 0.02% | 352 |
|
|
2017
Q1 | – | Sell |
-71,428
| Closed | -$295K | – | 569 |
|
|
2016
Q4 | $295K | Sell |
71,428
-151,405
| -68% | -$625K | 0.04% | 341 |
|
|
2016
Q3 | $1.81M | Buy |
222,833
+135,663
| +156% | +$1.1M | 0.2% | 136 |
|
|
2016
Q2 | $680K | Buy |
87,170
+63,579
| +270% | +$496K | 0.09% | 272 |
|
|
2016
Q1 | $182K | Buy |
+23,591
| New | +$182K | 0.03% | 498 |
|
|
2014
Q1 | – | Sell |
-61,651
| Closed | -$205K | – | 420 |
|
|
2013
Q4 | $205K | Buy |
+61,651
| New | +$205K | 0.08% | 297 |
|